We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $19.8B
1-Year Est. Return 31.12%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+31.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.8B
AUM Growth
+$2.5B
Cap. Flow
+$3.5B
Cap. Flow %
17.7%
Top 10 Hldgs %
39.03%
Holding
664
New
14
Increased
467
Reduced
94
Closed
89

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$333M
2
NVDA icon
NVIDIA
NVDA
+$242M
3
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$218M
4
AAPL icon
Apple
AAPL
+$213M
5
MSFT icon
Microsoft
MSFT
+$176M

Sector Composition

Rank Sector Weight
1 Technology 38.36%
2 Communication Services 12.13%
3 Consumer Discretionary 10.25%
4 Healthcare 6.37%
5 Consumer Staples 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACLX
576
DELISTED
Arcellx
ACLX
-39,904
Closed -$2.6M
AEIS icon
577
Advanced Energy
AEIS
$11.4B
-25,895
Closed -$5.42M
AIT icon
578
Applied Industrial Technologies
AIT
$12.4B
-37,419
Closed -$9.61M
ANAB icon
579
AnaptysBio
ANAB
$1.72B
-22,895
Closed -$1.11M
APG icon
580
APi Group
APG
$17.4B
-196,537
Closed -$7.52M
ARGX icon
581
argenx
ARGX
$53.8B
-1,410
Closed -$1.19M
ARVN icon
582
Arvinas
ARVN
$517M
-49,531
Closed -$587K
ARWR icon
583
Arrowhead Research
ARWR
$10.5B
-11,542
Closed -$766K
ASND icon
584
Ascendis Pharma A/S
ASND
$17.1B
-1,799
Closed -$384K
ATI icon
585
ATI
ATI
$25.4B
-78,117
Closed -$8.96M
ATMU icon
586
Atmus Filtration Technologies
ATMU
$4.19B
-89,857
Closed -$4.66M
AZN icon
587
AstraZeneca
AZN
$262B
-120,496
Closed -$22.2M
BBIO icon
588
BridgeBio Pharma
BBIO
$15.9B
-84,407
Closed -$6.46M
BELFB
589
Bel Fuse Inc Class B
BELFB
$3.85B
-89,918
Closed -$15.3M
BMRN icon
590
BioMarin Pharmaceuticals
BMRN
$11.5B
-5,376
Closed -$319K
BWXT icon
591
BWX Technologies
BWXT
$15.7B
-37,583
Closed -$6.5M
CELC icon
592
Celcuity
CELC
$4.31B
-28,233
Closed -$2.82M
CGEM icon
593
Cullinan Oncology
CGEM
$1.09B
-37,519
Closed -$388K
CGNX icon
594
Cognex
CGNX
$10.7B
-243,136
Closed -$8.75M
CGON icon
595
CG Oncology
CGON
$6.34B
-36,597
Closed -$1.52M
CMC icon
596
Commercial Metals
CMC
$7.35B
-45,380
Closed -$3.14M
CMPX icon
597
Compass Therapeutics
CMPX
$369M
-101,676
Closed -$546K
COGT icon
598
Cogent Biosciences
COGT
$6.68B
-107,924
Closed -$3.83M
CRNX icon
599
Crinetics Pharmaceuticals
CRNX
$8.88B
-8,767
Closed -$408K
CRVS icon
600
Corvus Pharmaceuticals
CRVS
$1.25B
-80,893
Closed -$623K

Similar funds

NEOS Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, NEOS Investment Management held 664 positions worth $19.8B, up 14% from $17.3B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

NEOS Investment Management deployed $3.5B of net new capital in Q1 2026, opening 14 new positions and adding to 467 existing holdings. Its largest new stake was Enbridge: 841,618 shares worth $45.5M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Caterpillar, an estimated $19M trimmed.

  • NEOS Investment Management's largest Q1 2026 buy was Enbridge: 841,618 shares worth $45.5M.
  • NEOS Investment Management added most to Walmart Inc in Q1 2026, an estimated $333M increase.
  • NEOS Investment Management's biggest Q1 2026 reduction was Caterpillar, cutting an estimated $19M.
  • NEOS Investment Management fully exited iShares Broad USD High Yield Corporate Bond ETF in Q1 2026, selling an estimated $62.6M.
  • NEOS Investment Management's ten largest holdings make up 39% of its $19.8B portfolio in Q1 2026.
  • NEOS Investment Management opened 14 new positions and closed 89 in Q1 2026.
  • NEOS Investment Management's portfolio value rose 14% quarter-over-quarter to $19.8B.

Based on NEOS Investment Management's 13F filing for Q1 2026, filed 15 May 2026.